Bronchiolitis, a lower respiratory tract infection which causes inflammation of the small airways in infants, imposes the largest health care burden on hospital admissions worldwide, with up to 15 % of admissions to intensive care.

Nasal High Flow (NHF) therapy has emerged as a new method to support the breathing of these infants avoiding intensive care admission. We have shown in a previous large study that NHF therapy can be used in regional and metropolitan hospitals and reduces the need to transfer infants to a specialised children’s hospital. This new project entails working with six of the regional Queensland hospitals from the previous study to explore the optimal way to translate the new knowledge into practice.

We will compare three sites provided with structured educational support to three sites with no additional educational support. We suspect that the centres receiving the additional support will retain the knowledge and skill level to maintain and sustain optimal improved outcomes and have better uptake and adherence to evidence based NHF therapy guidelines for admitted infants with bronchiolitis.